Isogenica

Isogenica is a contract discovery company specialising in VHH single-domain antibody discovery, offering what it describes as the world's largest synthetic VHH library alongside its proprietary screening platform.

The company partners with pharmaceutical and biotechnology companies to identify high-affinity antibody candidates against novel targets, providing both library screening services and licensing of its oligonucleotide construction technology.

Based at Chesterford Research Park, Isogenica has supported multiple programmes that have advanced to clinical stage.